Advances in nanotechnology-based medicine offer excellent opportunity to design nanosized entities comprising pharmaceutical agents that can potentially track undruggable diseases (typically by small molecule drug) including cancer.One of the approaches is to deliver engineered biomolecules (nucleic acids or proteins) using variety of delivery vectors[1].